Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Design of angiotensin converting enzyme inhibitors

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1: The known active site of carboxypeptidase A and a hypothetical model of the active site of ACE.
Figure 2

References

  1. Goldblatt, H., Lynch, J., Hanzal, R.F. & Summerville, W.W. Studies on experimental hypertension, I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J. Exp. Med. 59, 347– 379 (1934).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  2. Peart, W.S. Renin-angiotensin system. N. Engl. J. Med. 292, 302–306 (1975).

    CAS  Article  PubMed  Google Scholar 

  3. Skeggs, L.T., Kahn, J.R. & Shumway, N.P. Preparation and function of the hypertensin-converting enzyme. J. Exp. Med. 103, 295– 299 (1956).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  4. Ng, K.K.F. & Vane, J.R. Conversion of angiotensin I to angiotensin II. Nature 216, 762–766 (1967).

    CAS  Article  PubMed  Google Scholar 

  5. Cushman, D.W. & Cheung, H.S. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem. Pharmacol. 20, 1637–1648 ( 1971).

    CAS  Article  PubMed  Google Scholar 

  6. Steitz, T.A., Ludwig, M.L., Quiocho, F.A. & Lipscomb, W.N. The structure of carboxypeptidase A. V. Studies of enzyme-substrate and enzyme-inhibitor complexes at 6 Å resolution. J. Biol. Chem. 242 , 4662–4668 (1967).

    CAS  PubMed  Google Scholar 

  7. Cushman, D.W., Cheung, H.S., Sabo, E.F. & Ondetti, M.A. in Advances in Pharmacology and Therapeutics II vol. 3 (eds. Yoshida, H, Hasihara, Y. & Ebashi, S.) 249–258 (Pergamon, New York, 1982).

    Google Scholar 

  8. Ferreira, S.H., Bartelt, D.C. & Greene, L.J. Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom. Biochemistry 9, 2583–2593 (1970).

    CAS  Article  PubMed  Google Scholar 

  9. Ondetti, M.A., Williams, N.J., Sabo, E.F., Pluscec, J., Weaver, E.R. & Kocy, O. Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis. Biochemistry 10, 4033– 4039 (1971).

    CAS  Article  PubMed  Google Scholar 

  10. Cheung, H.S. & Cushman, D.W. Inhibition of homogeneous angiotensin-converting enzyme of rabbit lung by synthetic venom peptides of Bothrops jararaca . Biochim. Biophys. Acta 293, 451– 463 (1973).

    CAS  Article  PubMed  Google Scholar 

  11. Byers, L.D. & Wolfenden, R. Binding of the biproduct analog benzylsuccinic acid by carboxypeptidase A. Biochemistry 12, 2070–2078 (1973).

    CAS  Article  PubMed  Google Scholar 

  12. Ondetti, M.A., Rubin, B & Cushman, D.W. Design of specific inhibitors of angiotensin-converting enzyme: New class of orally active antihypertensive agents. Science 196, 441–444 ( 1977).

    CAS  Article  PubMed  Google Scholar 

  13. Cushman, D.W., Cheung, H.S., Sabo, E.F. & Ondetti, M.A. Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids. Biochemistry 16, 5484–5491 (1977).

    CAS  Article  PubMed  Google Scholar 

  14. Ondetti, M.A. From peptides to peptidases: A chronicle of drug discovery. Annu. Rev. Pharmacol. 34, 1–16 (1994).

    CAS  Article  Google Scholar 

  15. Case, D.B. et al. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin. Am. J. Med. 61, 790–796 (1976).

    CAS  Article  PubMed  Google Scholar 

  16. Monzingo, A.F. & Matthews, B.W. Structure of a mercaptan-thermolysin complex illustrates mode of inhibition of zinc proteases by substrate-analogue mercaptans. Biochemistry 21, 3390–3394 (1982).

    CAS  Article  PubMed  Google Scholar 

  17. Ondetti, M.A. & Cushman, D.W. Angiotensin-converting enzyme inhibitors: Biochemical properties and biological activities. CRC Crit. Rev. Biochem. 16, 381–411 (1984).

    CAS  Article  PubMed  Google Scholar 

  18. Weber, M.A. Comparison of type I angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors in the treatment of hypertension. J. Hypertens. Suppl. 15, S31–S36 ( 1977).

    Article  Google Scholar 

  19. Summers, J.B. & Davidsen, S.K. Matrix Metalloproteinase Inhibitors and Cancer. Ann. Reports Med. Chem. 33, 131–140 (1998).

    CAS  Article  Google Scholar 

  20. Burnett, J.C. Jr. Vasopeptidase inhibition: a new concept in blood pressure management. J. Hypertens. 17, S37– 43 (1999).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Cushman, D., Ondetti, M. Design of angiotensin converting enzyme inhibitors. Nat Med 5, 1110–1112 (1999). https://doi.org/10.1038/13423

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/13423

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing